on 30 Apr 2024
Last Applicant/ Owned by
NO. 658, BINAN ROAD, BINJIANG DISTRICT,HANGZHOU 310053 ZHEJIANG PROVINCE
CN
Serial Number
79350047 filed on 15th Jul 2022
Registration Number
7369448 registered on 30th Apr 2024
Correspondent Address
MARK E. BANDY
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous Read More
Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming
N/A
N/A
Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; Drugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; Drugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases
N/A
N/A
No 79350047
No Service Mark
No LIU-54671
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
27th Oct 2024 | GENERIC MADRID TRANSACTION SENT TO IB |
26th Oct 2024 | GENERIC MADRID TRANSACTION CREATED |
30th Jul 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
30th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
30th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
17th Mar 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
26th Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
21st Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
19th Feb 2024 | NOTIFICATION PROCESSED BY IB |
13th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |